KCT0008055
Completed
未知
A 12 week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Lactobacillus plantarum LMT1-48 on Reducing Body Fat
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Endocrine, nutritional and metabolic diseases
- Sponsor
- Global Medical Research Center
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) A person who is 19 years of age or older and under 70 years of age
- •2\) Those with a body mass index (BMI) of 25 kg/m² or more and less than 30 kg/m² for visit 1 and visit 2
- •3\) A person who agrees to participate in the human body application test and prepares a written consent form before the human body application test begins
Exclusion Criteria
- •1\) Serious cardiovascular system, immune system, respiratory system, gastrointestinal/hepatic and biliary tract, kidney and urinary system, nervous system, mental,
- •A person who is currently being treated for infectious diseases, etc. (However, he/she may participate in the test at the discretion of the tester considering the condition of the person subject to the human body application test)
- •2\) Those diagnosed with cancer within 5 years as of Visit 1 (excluding thyroid cancer, early cervical cancer (endothelial cancer))
- •3\) Within 1 month (30 days) of visit 1, weight\-affecting drugs (such as appetite suppressants, liposuction inhibitors, GLP\-1 receptor agonists), psychiatric drugs such as depression and schizophrenia, beta\-blockers, diuretics, contraceptives, thyroid hormones), hyperlipidemia drugs (including omega3\), health\-controlled, phytosanitary and dietary supplements
- •4\) A person who has administered antibiotics and intestinal medications within two weeks as of Visit 1
- •5\) A person who has administered or ingested probiotics, prebiotics, and lactobacillus products continuously (more than 4 times a week) within 2 weeks as of Visit 1
- •6\) A person who has undergone obesity surgery within one year based on visit 1
- •7\) Patients with uncontrolled hypertension (systolic blood pressure of 160 mmHg or more or diastolic blood pressure of 100 mmHg or more, measured after stabilization for 10 minutes)
- •8\) Diabetes patients who have an empty stomach blood sugar of 126 mg/dL or higher or who are taking anti\-diabetic drugs (e.g., oral hypoglycemic drugs, insulin, etc.)
- •9\) Those with a TSH of not more than 0\.1 µIU/mL or not more than 10 µIU/mL
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
The Efficacy and Safety of MKC on the Skin Wrinkle Improvement and MoisturizingKCT0006416Holistic Bio100
Completed
Not Applicable
A 12 week, Randomized, Double-Blind, Placebo-Controlled, Exploratory Clinical Trial for the Evaluation of the Efficacy and Safety of BA on Inflammatory Bowel Disease(Ulcerative Colitis)KCT0008045Hongcheon Institute of Medicinal Herb30
Completed
Not Applicable
Efficacy and Safety of GELTECHCollagen on the skin wrinkle improvement and moisturizing; Placebo-Clinical trialDiseases of the skin and subcutaneous tissueKCT0006500GELTECH100
Recruiting
Not Applicable
Efficacy and Safety of PB203 on the skin wrinkle improvement and moisturizing; Placebo-Clinical trialKCT0007013Global Medical Research Center100
Completed
Not Applicable
A 12 week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of PB1 on Reducing Body FatKCT0008095Kangbuk Samsung Medical Center30